Pamidronate Disodium for Injection

This product is a bisphosphonate drug. In vitro and animal tests have shown that it can strongly inhibit the dissolution of hydroxyapatite and the activity of osteoclasts, and has a very significant inhibitory effect on bone absorption. It has an analgesic effect on pain caused by osteolytic bone metastasis of cancer, and can also be used to treat hypercalcemia caused by cancer.

The main ingredient of this product is: Pamidronate disodium. Its chemical name is: 3-amino-1-hydroxypropylidene-1,1-bisphosphonic acid disodium pentahydrate.

This product is a colorless clear liquid.

Hypercalcemia complicated by malignancy and bone pain caused by osteolytic cancer metastasis.

Treatment of bone metastasis pain: dilute in 0.9% saline or 5% glucose solution without calcium ions before use. Slow intravenous drip for more than 4 hours, the concentration should not exceed 15mg/125ml, and the drip rate should not exceed 15-30mg/2 hours. 30-60mg per dose. Treatment of hypercalcemia: should be strictly based on blood calcium concentration, and medication should be used as appropriate under the guidance of a doctor. Generally: blood calcium mmol/L4.0mg%16.0Dose mg

A small number of patients may experience mild nausea, chest pain, chest tightness, dizziness, fatigue, and slight changes in liver and kidney function, and occasionally fever.

Patients with a history of allergy to this product and bisphosphonates are contraindicated.

Not yet clear.

Keep tightly closed.

15mg

Shenzhen Salubris Pharmaceuticals Co., Ltd.

• Founded in:

  1998-11-03

• Address:

  Area A, 4th Floor, Digital Peninsula, No. 289, Hongliu Road, Fubao Community, Fubao Street, Futian District, Shenzhen

• Tax NO.:

  91440300708453259J

• Registered Funds:

  1,114.816535 yuan

• Website:

  Log in to view

• Email:

  Log in to view